Clinical trial
Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV…
NCT00003501 · Burzynski Research Institute, Other · Terminated
Key facts
| NCT number | NCT00003501 |
|---|---|
| Title | Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma |
| Official title | Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma, High Grade |
| Lead sponsor | Burzynski Research Institute, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-hodgkins Lymphoma |
| Intervention type | Drug |
| Interventions | Antineoplaston therapy (Atengenal + Astugenal) |
| Enrollment | 2 |
| Start date | Apr 10, 1996 |
| Primary completion | Jul 2, 2003 |
| Completion | Jul 2, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: